Inj naloxone hcl nos, 0.01mg
Products billed under this code include Naloxone HCl.
Payment limit per 0.01 MG, by effective quarter, 3Q25 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Naloxone HCl.
Payment limit per 0.01 MG, by effective quarter, 3Q25 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Naloxone HCl | Henry Schein Inc. | 00404-9773-01 | 40 | $3.04 |
| Naloxone HCl | Henry Schein Inc. | 00404-9920-01 | 40 | $3.04 |
| Naloxone HCl | Henry Schein Inc. | 00404-9921-02 | 200 | $15.20 |
| Naloxone HCl | Henry Schein Inc. | 00404-9922-02 | 200 | $15.20 |
| Naloxone HCl | Henry Schein Inc. | 00404-9923-01 | 40 | $3.04 |
| Naloxone HCl | Pfizer Inc | 00409-1215-01 | 400 | $30.40 |
| Naloxone HCl | Pfizer Inc | 00409-1219-01 | 10000 | $760.00 |
| Naloxone HCl | Pfizer Inc | 00409-1782-69 | 400 | $30.40 |
| Naloxone HCl | Hikma Pharmaceuticals USA Inc. | 00641-6132-25 | 1000 | $76.00 |
| Naloxone HCl | Hikma Pharmaceuticals USA Inc. | 00641-6193-10 | 400 | $30.40 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Naloxone HCl | Hikma Pharmaceuticals USA Inc. | 00641-6205-10 | 4000 | $304.00 |
| Naloxone HCl | Baxter Healthcare Corporation | 36000-0308-10 | 400 | $30.40 |
| Naloxone HCl | Baxter Healthcare Corporation | 36000-0310-02 | 400 | $30.40 |
| Naloxone HCl | Endo USA, Inc. | 42023-0224-01 | 200 | $15.20 |
| Naloxone HCl | Baxter Healthcare Corporation | 43066-0142-10 | 2000 | $152.00 |
| Naloxone HCl | Dr. Reddy's Laboratories Inc. | 43598-0750-10 | 2000 | $152.00 |
| Naloxone HCl | Dr. Reddy's Laboratories Inc. | 43598-0750-58 | 2000 | $152.00 |
| Naloxone HCl | A-S Medication Solutions | 50090-3294-00 | 400 | $30.40 |
| Naloxone HCl | A-S Medication Solutions | 50090-5427-00 | 400 | $30.40 |
| Naloxone HCl | A-S Medication Solutions | 50090-6491-00 | 400 | $30.40 |
| Naloxone HCl | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1238-01 | 40 | $3.04 |
| Naloxone HCl | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1239-01 | 200 | $15.20 |
| Naloxone HCl | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1239-03 | 2000 | $152.00 |
| Naloxone HCl | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1242-01 | 40 | $3.04 |
| Naloxone HCl | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1242-03 | 2000 | $152.00 |
| Naloxone HCl | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1385-01 | 400 | $30.40 |
| Naloxone HCl | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1586-01 | 200 | $15.20 |
| Naloxone HCl | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1586-03 | 2000 | $152.00 |
| Naloxone HCl | Henry Schein Inc. | 51662-1673-01 | 400 | $30.40 |
| Naloxone HCl | Eugia US LLC | 55150-0328-10 | 4000 | $304.00 |
| Naloxone HCl | Eugia US LLC | 55150-0345-10 | 2000 | $152.00 |
| Naloxone HCl | Mylan Institutional LLC | 67457-0292-02 | 400 | $30.40 |
| Naloxone HCl | Mylan Institutional LLC | 67457-0299-10 | 4000 | $304.00 |
| Naloxone HCl | Mylan Institutional LLC | 67457-0599-02 | 400 | $30.40 |
| Naloxone HCl | Mylan Institutional LLC | 67457-0645-02 | 400 | $30.40 |
| Naloxone HCl | Mylan Institutional LLC | 67457-0987-10 | 4000 | $304.00 |
| Naloxone HCl | Mylan Institutional LLC | 67457-0992-02 | 400 | $30.40 |
| Naloxone HCl | Somerset Pharma, LLC | 70069-0071-10 | 400 | $30.40 |
| Naloxone HCl | Somerset Pharma, LLC | 70069-0072-10 | 4000 | $304.00 |
| Naloxone HCl | Lifestar Pharma | 70756-0658-10 | 400 | $30.40 |
| Naloxone HCl | Lifestar Pharma | 70756-0658-25 | 1000 | $76.00 |
| Naloxone HCl | Lifestar Pharma | 70756-0850-10 | 400 | $30.40 |
| Naloxone HCl | Civica, Inc. | 72572-0450-25 | 1000 | $76.00 |
| Naloxone HCl | Northstar RxLLC | 72603-0590-10 | 400 | $30.40 |
| Naloxone HCl | Northstar RxLLC | 72603-0590-25 | 1000 | $76.00 |
| Naloxone HCl | FreseniUS Kabi USA, LLC | 76045-0112-20 | 4800 | $364.80 |
| Naloxone HCl | FreseniUS Kabi USA, LLC | 76045-0114-10 | 960 | $72.96 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.076 | +$0.007 | 0.01 MG | Inj naloxone hcl nos, 0.01mg | v1, posted September 17, 2026 |
| 3Q26 | $0.069 | +$0.004 | 0.01 MG | Inj naloxone hcl nos, 0.01mg | v1, posted September 15, 2026 |
| 2Q26 | $0.065 | $0.00 | 0.01 MG | Inj naloxone hcl nos, 0.01mg | v1, posted September 15, 2026 |
| 1Q26 | $0.065 | −$0.01 | 0.01 MG | Inj naloxone hcl nos, 0.01mg | v1, posted September 15, 2026 |
| 4Q25 | $0.075 | +$0.007 | 0.01 MG | Inj naloxone hcl nos, 0.01mg | v1, posted September 8, 2026 |
| 3Q25 | $0.068 | – | 0.01 MG | Inj naloxone hcl nos, 0.01mg | v1, posted March 10, 2026 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.